Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R)

Astegolimab (Anti-IL-1RL1 / ST2 / IL-33R) is a human IgG2 monoclonal antibody that blocks IL-33 signaling by targeting ST2, the IL-33 receptor. It has the potential for chronic obstructive pulmonary disease (COPD), asthama treatment. MW :145.5 KD
Supplier Selleck Chemicals
Product # A2443
Sku # A2443-1mg*5
Pricing 1mg*5, $970.00
Feedback